News

Iconacy™ Orthopedic Implants, LLC Receives Food and Drug Administration Clearance to Market I-HIP™ Total Hip Replacement

Warsaw, Ind. September 12, 2012 – ICONACY Orthopedic Implants today announces its first clearance to market a total hip replacement system under the trademark name I-Hip.

 

“Products such as the I-Hip system align well with our overall strategy of providing clinically proven geometries of the highest quality while advancing technology,” says Kevin Cox, V.P. of Sales and Marketing. “This system will allow us to deliver a best in class hip with advanced wear characteristics at an optimum value.”

 

The I-Hip system consists of femoral stem and acetabular cup porous coated components intended for cementless, press-fit fixation, patented highly cross-linked polyethylene liners, and Co-Cr alloy femoral heads.

 

ABOUT ICONACY

ICONACY is an entrepreneurial orthopedic company started by seasoned professionals with a view focusing on the needs of patients, surgeons, and hospitals without the bureaucracy and costly infrastructure of a large organization. ICONACY will produce all of its product in the United States which will include hip, knee, and shoulder joint replacements. The commitment to U.S. based manufacturing demonstrates a long-term view toward quality and efficiency. Moreover, ICONACY is committed to providing best-in-class service to its customers, ultimately driving patient care and efficiency through the orthopedic market. ICONACY will do this by providing individualized service levels at the hospital setting while eliminating inefficiencies within the traditional supply chain.

 

ICONACY SAFE HARBOR STATEMENT
This press release contains forward looking statements within the safe harbor provisions of Securities Litigation Reform Act of 1995. Forward looking statements can be identified by such terms as “may”, “will”, “expects”, “believes”, “forecasts”, “targets”. These or any other statements are not guarantees of future performance. Readers of this should be not place undue reliance on forward-looking statements.